Work

A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the eastern cooperative oncology group study E2200

Year: 2006

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdl161

Authors: B.J. Giantonio, D.E. Levy, P.J. O'Dwyer, N.J. Meropol, P.J. Catalano, A.B. Benson

Institutions: University of Pennsylvania, Dana-Farber Cancer Institute, Fox Chase Cancer Center, Northwestern University

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute

Awards: G1042980396, ECOG Statistical Office Data Management Grant, G1422427855, G2017411191, G2733715607, ECOG Clinical Trials, G4412485521, Eastern Cooperative Oncology Group, ECOG Statistical Office, Eastern Cooperative Oncology Group Operations Office, EASTERN COOPERATIVE ONCOLOGY GROUP, G9000028455, G964706321

OpenAlex ID: W2111312975

FWCI: 10.23

Cites: 24

Cited by: 131

Related to: 10